High-rolling investors have positioned themselves bearish on Novo Nordisk (NYSE:NVO), and it's important for retail traders to take note.This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in NVO often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Novo Nordisk. This is not a typical pattern.
The sentiment among these major traders is split, with 36% bullish and 45% bearish. Among all the options we identified, there was one put, amounting to $94,500, and 10 calls, totaling $494,105.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $124.0 to $165.0 for Novo Nordisk over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale trades within a strike price range from $124.0 to $165.0 in the last 30 days.
Novo Nordisk Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
| NVO | PUT | SWEEP | BULLISH | 08/09/24 | $1.97 | $1.75 | $1.75 | $125.00 | $94.5K | 471 | 606 |
| NVO | CALL | SWEEP | BULLISH | 08/16/24 | $10.3 | $10.1 | $10.1 | $124.00 | $75.7K | 167 | 0 |
| NVO | CALL | SWEEP | BULLISH | 08/09/24 | $4.15 | $4.0 | $4.15 | $133.00 | $68.9K | 126 | 581 |
| NVO | CALL | SWEEP | NEUTRAL | 08/09/24 | $6.35 | $6.1 | $6.21 | $129.00 | $62.7K | 891 | 280 |
| NVO | CALL | SWEEP | BEARISH | 01/17/25 | $3.7 | $3.55 | $3.55 | $165.00 | $57.5K | 1.5K | 164 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Novo Nordisk's Current Market Status
- With a volume of 1,387,583, the price of NVO is up 2.38% at $132.31.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 7 days.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.
高額投資者已將自己定位爲看跌諾和諾德（紐約證券交易所代碼：NVO），散戶交易者注意這一點很重要。\ 這項活動今天通過Benzinga對公開期權數據的追蹤引起了我們的注意。這些投資者的身份尚不確定，但是NVO的如此重大舉措通常表明有人擁有特權信息。
今天，Benzinga的期權掃描儀發現了Novo Nordisk的11筆期權交易。這不是典型的模式。
這些主要交易者的情緒分歧，36％看漲，45％看跌。在我們確定的所有期權中，有一個看跌期權，金額爲94,500美元，還有10個看漲期權，總額爲494,105美元。
預測的價格區間
考慮到這些合約的交易量和未平倉合約，在過去的3個月中，鯨魚似乎一直將Novo Nordisk的價格定在124.0美元至165.0美元之間。
交易量和未平倉合約的發展
交易期權時，查看交易量和未平倉合約是一個強有力的舉動。這些數據可以幫助您跟蹤Novo Nordisk期權在給定行使價下的流動性和利息。下面，我們可以觀察過去30天內諾和諾德所有鯨魚交易的看漲和看跌期權交易量和未平倉合約的變化，其行使價在124.0美元至165.0美元之間。
諾和諾德期權活動分析：過去 30 天
觀察到的最大期權交易：
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
NVO | PUT | SWEEP | BULLISH | 08/09/24 | $1.97 | $1.75 | $1.75 | $125.00 | $94.5K | 471 | 606 |
NVO | CALL | SWEEP | BULLISH | 08/16/24 | $10.3 | $10.1 | $10.1 | $124.00 | $75.7K | 167 | 0 |
NVO | CALL | SWEEP | BULLISH | 08/09/24 | $4.15 | $4.0 | $4.15 | $133.00 | $68.9K | 126 | 581 |
NVO | CALL | SWEEP | NEUTRAL | 08/09/24 | $6.35 | $6.1 | $6.21 | $129.00 | $62.7K | 891 | 280 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $3.7 | $3.55 | $3.55 | $165.00 | $57.5K | 1.5K | 164 |
關於 Novo Nordisk
諾和諾德擁有全球品牌糖尿病治療市場約三分之一的份額，是全球領先的糖尿病護理產品提供商。該公司總部位於丹麥，生產和銷售各種人用和現代胰島素、注射型糖尿病治療藥物（如 GLP-1 療法）、口服抗糖尿病藥物和肥胖療法。Novo還有一個生物製藥板塊（約佔收入的10％），專門研究血友病和其他疾病的蛋白質療法。
諾和諾德的當前市場狀況
NVO的交易量爲1,387,583美元，上漲2.38％，至132.31美元。
RSI 指標暗示，標的股票目前在超買和超賣之間保持中立。
下一份業績預計將在7天后公佈。
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用 Benzinga Pro 了解諾和諾德的最新期權交易，獲取實時提醒。
